改善脂质控制的西班牙共识对急性冠状动脉综合征入院患者的影响
Carlos Escobar1, Vivencio Barrios2, Angel Cequier3
1La Paz University Hospital, Madrid, Spain (Dr Escobar).
Journal of clinical lipidology
|October 14, 2023
概括
实施西班牙心脏病学会的共识显著改善了二次预防患者的脂质控制. 这在实施后三个月内增强了LDL-C的降低.
科学领域:
- 心脏病学 心脏病学
- 临床实践指南 临床实践指南
- 脂质管理 脂质管理
背景情况:
- 西班牙心脏病学会在2020年发布了一项共识,旨在提高需要二次预防的患者的脂质控制.
- 有效的脂质管理对于预防二次心血管事件至关重要.
研究的目的:
- 评估实施2020年西班牙脂质共识对临床实践的影响.
- 评估降脂疗法和低密度脂蛋白胆固醇 (LDL-C) 控制的变化.
主要方法:
- 一项非干预性多中心研究,比较了急性冠状动脉综合征 (ACS) 患者的前性和后性队列.
- 前性队列 (n=245) 接受了共识后的护理实施,而后性队列 (n=271) 作为历史对照.
- 两个队列都被跟踪了3个月,包括标准要求LDL-C>55毫克/分升,尽管之前的降脂疗法.
主要成果:
- 与回顾性队列相比,前性队列显示埃泽胺使用量显著增加 (58.4%与33.2%) 和他类药物剂量增加 (11.4%与3.3%).
- 预期队列中显著更多的患者在3个月内达到LDL-C <55 mg/dL (45.6%与33.5%相比).
- 在离院时使用他类药物或PCSK9抑制剂时没有观察到显著差异.
结论:
- 西班牙脂质共识的实施使得二次预防患者的LDL-C控制得到改善.
- 增强的脂质管理策略导致在短时间的随访期间更好地实现LDL-C目标.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Acute Coronary Syndrome III: Diagnostic Studies
9
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
20
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
678
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
678
Acute Coronary Syndrome V: Nursing Management
16
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
16


